1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow MM-151: new trials by email Literature Review of MM-151 trials Research Report on MM-151
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of MM-151 + Nal-IRI + 5-FU + Leucovorin in RAS/RAF Wild-type Metastatic Colorectal Cancer MM-151, nal-IRI, Leucovorin - Colorectal Cancer | Phase 1 / Phase 2 | Withdrawn | Merrimack Pharmaceuticals | 2016-07-01 | 2017-01-11 |
Colorectal Neoplasms (1) · Neoplasms (1)